3:59pm PDT - April 21st, 2023
Universal Influenza Candidate Vaccine Performs Well in Phase 1 Trial | NIH: National Institute of Allergy and Infectious Diseases https://t.co/l8JRP3If2U
0 retweets 0 likes - OSAP.org (@OSAPtweets)Universal Influenza Candidate Vaccine Performs Well in Phase 1 Trial | NIH: National Institute of Allergy and Infectious Diseases https://t.co/l8JRP3If2U
0 retweets 0 likes - OSAP.org (@OSAPtweets)